A landmark, multi-year observational study will profile thousands of individuals with depression, bringing together genomics, neuroimaging, clinical assessments, and patient-reported outcomes to identify biomarkers that can guide drug development and personalize depression care.

Why has psychiatry lacked major therapeutic advances?

The first antidepressants were discovered by accident, when clinicians noticed that a tuberculosis drug, iproniazid, lifted the mood of patients.